The “Dmed Evolution Tower”  was completed on April 30, 2026. provides all solutions, including research and development of medical devices, clinical trials, Korean Food and Drug Administration, US FDA, European CE certification, and biomedical device production. All managers will be able to obtain results faster than the existing procedures. All administrative procedures for registration of medical devices and the entire production process will be provided under OEM and ODM contracts. All documents to the on-site GMP inspection and foreign quality inspection will be provided in English and Korean or in the applicable country’s language as required according to the latest ISO regulations. All quality documents will be equipped with a remote screening system that allows the “Quality Auditor of the other country” to directly review the authorized scope and data in the form of electronic documents.